3 are very interesting.
Full IPO calendar & reports HERE
In order of largest IPO first.
(1) Based in Canonsburg, PA,Rice Midstream Partners LP ($RMP) scheduled a $500 million IPO on NYSE with a market capitalization of $1.15 billion at a price range midpoint of $20 for Wednesday, Dec. 17, 2014.
RMP is a fee-based, growth-oriented limited partnership formed by Rice Energy Inc. (NYSE: RICE) to own, operate, develop and acquire midstream assets in the Appalachian Basin. RICE has a market cap of $3.26 billion
(2) Based in New York, NY,On Deck Capital ($ONDK) scheduled a $170 million IPO on NYSE with a market capitalization of $1.1 billion at a price range midpoint of $17 for Wednesday, Dec. 17, 2014.
ONDK is a leading online platform for small business lending. ONDK is seeking to transform small business lending by making it efficient and convenient for small businesses to access capital.
(3) Based in Seattle, WA,Juno Therapeutics ($JUNO) scheduled a $153 million IPO on Nasdaq with a market capitalization of $1.3 billion at a price range midpoint of $16.50 for Friday, Dec. 19, 2014.
JUNO is building a fully-integrated biopharmaceutical company focused on revolutionizing medicine by re-engaging the body’s immune system to treat cancer.
(4) Based in Houston, TX,Bellicum Pharmaceuticals ($BLCM) scheduled a $100 million IPO on Nasdaq with a market capitalization of $397 million at a price range midpoint of $16 for Thursday, Dec. 18, 2014.
BLCM is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors, as well as orphan inherited blood disorders.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer